Clear ×
Crinetics Pharmaceuticals, Inc. CRNX

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Sep 1, 2026 8-K 20 signals fired · top 15
Other
Director Officer Indemnification Provision Classified Board Director Election Adjournment Proposal Voting Requirement Stock Certificate Signature Requirement Board Committee Member Listing Corporate Organization And Standing Representation Merger Subsidiary Creation President Duties Defined Quorum Adjournment Provision Record Date Procedures Disclosed Form 8K Filing Disclosure Record Date Disclosure Transfer And Demand Rights Limitations Ltip Plan Title Citation Employee Director Compensation Waiver
Aug 28, 2026 8-K 1 signal fired
Other
Adjournment Proposal Voting Requirement
Aug 19, 2026 8-K 3 signals fired
Other
Proxy Statement Mailing Date Merger Proxy Statement Disclosure Net Loss Reported
Aug 14, 2026 8-K 1 signal fired
Other
Form 8K Filing Disclosure
Aug 3, 2026 10-Q 26 signals fired · top 15
Other
Cash Flow Statement Investing Activities Net Loss Reported Financing Activities Cash Flow Disclosure Shares Outstanding Disclosure Operating Lease Rent Expense Disclosed Anti Takeover Provision Disclosure Fast Track Designation Received Fast Track Granted Other Income Expense Disclosure Breakthrough Therapy Granted Shareholder Dilution Warning
Core
Regulatory Designation Only Indication Expansion Lead Asset Progress
Biotech v3
Ai Drug Discovery Investment
Aug 3, 2026 8-K 20 signals fired · top 15
Other
Net Loss Reported Fast Track Granted Liquidity Position Snapshot Disclosed Fast Track Designation Received Orphan Status Granted Breakthrough Therapy Granted Rmat Designation Received
Healthcare
Reimbursement Improving Volume Inflecting
Biotech Risk
Orphan Drug Designation Accelerated Approval
Core
Indication Expansion Lead Asset Progress Regulatory Designation Only
SaaS
Membership Growing
Jul 10, 2026 8-K 1 signal fired
Other
Non Solicitation Covenant
Jun 22, 2026 8-K 2 signals fired
Other
Auditor Appointment Ratification Quorum Presence Disclosed
May 7, 2026 10-Q 19 signals fired · top 15
Other
Segment Aggregation Disclosure Ipo Net Proceeds Disclosure Financing Activities Cash Flow Disclosure Cash Flow Statement Investing Activities Net Loss Reported Forward Looking Statement Definition Equity Plan Share Reserve Disclosure Shares Outstanding Disclosure Other Income Expense Disclosure Codm Segment Reporting Disclosure Capital Raising Uncertainty Disclosed
Core
Indication Expansion Lead Asset Progress Clinical Trial Result
Healthcare
Reimbursement Improving
May 7, 2026 8-K 16 signals fired · top 15
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Enrollment Ahead Of Schedule Kol Endorsement
Healthcare
Reimbursement Improving Volume Inflecting
Core
Patient Enrollment Velocity Indication Expansion Lead Asset Progress Clinical Trial Result Clinical Hold
SaaS
Usage Growth Membership Growing Same Client Revenue Growing
Biotech Risk
Crl Received
Apr 10, 2026 8-K 8 signals fired
Other
Ip Assignment To Company Confidential Information Definition Non Assignment Clause Termination For Material Breach Clause Rsu Psu Vesting Schedule Disclosed Power Of Attorney Disclosure Arbitrator Selection Procedure
Core
Management Exodus